Skip to Main Content

Good morning, everyone, and how are you today? We are doing just fine, thank you, especially since the Pharmalot campus is unusually quiet. A short person is sleeping in and the official mascot is snoozing happily in a corner. This leaves us to the matter at hand, which is foraging for items of interest. On that note, please enjoy the tidbits assembled here and, if you choose to do so, join us for a quick cup of stimulation. Our flavor today is hot-buttered rum, for those who care. Meanwhile, have a smashing day and please do keep in touch. …

The Food and Drug Administration approved a new tuberculosis medicine that shortens and improves treatment for the hardest-to-treat cases, the Associated Press explains. This is the first TB drug from a nonprofit group. The TB Alliance developed pretomanid with help from charities and government agencies. The pill was approved for use with two other antibiotics. Decades of incomplete or ineffective treatment have resulted in TB strains that are drug-resistant and not killed by standard medicines.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Comments are closed.